A Conversation With The Havas Team: How to Use Omnichannel and CX to Succeed With Launches in 2023 and Beyond
Jun 7, 2023
auto_awesome
Guests Richard Shaffer, Pat Thistlethwaite, and Tara Stewart from Havas discuss the changes in pharma go-to-market models post-COVID, using content to drive behavior change for HCPs, the right measurement framework for engagement data, and the collection and use of first-party data by pharma companies.
Pharmaceutical companies are shifting to a digital-first approach to engage healthcare professionals in the post-COVID world and combat digital fatigue.
Pharma companies are recognizing the importance of content strategy and science to drive behavior change and personalize their marketing efforts.
Deep dives
Shift in Expectations from Patients and HCPs
Patients and healthcare professionals now expect pharmaceutical companies to provide experiences on par with Netflix, Disney Plus, and Amazon, which has led to a shift in the industry and the incorporation of expertise from outside the pharmaceutical sector.
Challenges of Digital Communication
The digital landscape has become saturated with communication, making it difficult for pharma companies to cut through the clutter and effectively reach their target audience. Many companies have shifted to a digital-first approach but still struggle to reduce the overwhelming amount of content and focus on what is truly important.
Content Strategy and Customer Experience
Pharmaceutical companies are recognizing the need for content strategy and content science to drive behavior change and personalize their marketing efforts. The focus is shifting from tactical execution to a more strategic and scientific approach that aligns with specific objectives and changes in customer attitudes and behaviors.
Building Data Capability and Creating Value Exchange
Pharma companies are consolidating their data analysis efforts, building core data functions, and breaking down data silos to better understand their customers. They are also working on establishing a value exchange with customers by delivering personalized experiences and relevant content in return for data. However, challenges remain in properly executing these initiatives and effectively measuring their impact.
Pharma/AOR Executives: Make sure you grab a complimentary copy of our 3-Step Guide To Using the Netflix-Like Content Hubs to Engage HCPs in 30-90 Days 👉 3-Step Free Guide
In this episode, Bozidar is joined by Richard Shaffer, Associate Managing Director at Havas, Pat Thistlethwaite, Chief Experience Officer at Havas, and Tara Stewart, Managing Director at Havas Health & You.
They discuss:
How pharma companies have changed their go-to-market models to meet the needs of their HCPs in the post-COVID world and combat digital fatigue
How to use content to drive behavior change on an individual HCP level
What the right measurement framework to use for HCP engagement data, media, content, and AB testing is
How pharma companies can collect and use first-party data, and why that matters
“Pharma Launch Secrets” is a podcast by Evermed and hosted by CEO Bozidar Jovicevic. We host direct, actionable conversations with world-leading pharma launch experts and help you stay up-to-date with the latest trends and strategies to help you launch your product successfully.